Consistent with this is the finding that ROS, including tumor-derived ROS, can trigger the accumulation of SUMO-specific protease 3 (SENP3), a protein crucial for deSUMOylation of BACH2, in Tregs, which results in the repression of genes associated with effector CD4+ T cells (100). The gene discussed is CD4; the disease is neoplasm.